Fig. 10From: Systematic analysis based on the cuproptosis-related genes identifies ferredoxin 1 as an immune regulator and therapeutic target for glioblastomaThe screened drugs for GBM treatment. A The top 15 drugs that high FDX1 expression indicates sensitivity and resistance. B-E IC 50 value of 4 representative drugs that indicate resistance. F-I IC 50 value of 4 representative drugs that indicate sensitivityBack to article page